Literature DB >> 15654194

The right ventricle in pulmonary hypertension.

Kelly M Chin1, Nick H S Kim, Lewis J Rubin.   

Abstract

Pulmonary arterial hypertension (PAH) is a term used to classify a variety of conditions that share in common an injury to the pulmonary vasculature that produces elevations in pulmonary arterial pressure. However, it is the integrity of right ventricular function, rather than the degree of vascular injury, that is the major determinant of symptoms and survival in PAH. The article will review the normal structure and function of the right ventricle and summarize the impact of PAH and its treatments on right ventricular function.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15654194     DOI： 10.1097/00019501-200502000-00003

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN： 0954-6928            Impact factor:   1.439


  112 in total

Review 1.  Pulmonary arterial hypertension associated with systemic sclerosis.

Authors:  Stephen C Mathai; Paul M Hassoun
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

Review 2.  Redefining the role of cardiovascular imaging in patients with pulmonary arterial hypertension.

Authors:  Benjamin H Freed; Amit R Patel; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

3.  The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension.

Authors:  Stephen C Mathai; Milo A Puhan; Diana Lam; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

Review 4.  Lung involvement in systemic sclerosis.

Authors:  Paul M Hassoun
Journal:  Presse Med       Date:  2010-12-30       Impact factor: 1.228

5.  Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner.

Authors:  Allan Lawrie; Abdul G Hameed; Janet Chamberlain; Nadine Arnold; Aneurin Kennerley; Kay Hopkinson; Josephine Pickworth; David G Kiely; David C Crossman; Sheila E Francis
Journal:  Am J Pathol       Date:  2011-08-09       Impact factor: 4.307

6.  Right-sided heart failure: diagnosis and treatment strategies.

Authors:  Jennifer Cowger Matthews; Todd F Dardas; Michael P Dorsch; Keith D Aaronson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-08

7.  Use of the myocardial performance index to assess right ventricular function in infants with pulmonary hypertension.

Authors:  Neil Patel; John F Mills; Michael M H Cheung
Journal:  Pediatr Cardiol       Date:  2008-08-15       Impact factor: 1.655

8.  CT signs of right ventricular dysfunction correlated with echocardiography-derived pulmonary arterial systolic pressure: incremental value of the pulmonary arterial diameter index.

Authors:  Soyeoun Lim; Heon Lee; Soo Jeong Lee; Jae Kyun Kim; Jon Suh; Eun Hye Lee; Sang Hyun Paik
Journal:  Int J Cardiovasc Imaging       Date:  2013-11-06       Impact factor: 2.357

9.  Skeletal muscle mitochondrial dysfunction precedes right ventricular impairment in experimental pulmonary hypertension.

Authors:  Irina Enache; Anne-Laure Charles; Jamal Bouitbir; Fabrice Favret; Joffrey Zoll; Daniel Metzger; Monique Oswald-Mammosser; Bernard Geny; Anne Charloux
Journal:  Mol Cell Biochem       Date:  2012-10-26       Impact factor: 3.396

10.  Choice of marker for assessment of RV dysfunction in acute pulmonary embolism : NT-proBNP, pulmonary artery systolic pressure, mean arterial pressure, or blood pressure index.

Authors:  H Ates; I Ates; H Kundi; F M Yilmaz
Journal:  Herz       Date:  2016-12-13       Impact factor: 1.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.